DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Carmustine
Carmustine
Australian Public Assessment Report for Aminolevulinic Acid Hcl
NOV 1 72010 1.0 Submitter
Primary Central Nervous System Lymphoma: Consolidation Strategies
Wear the Battle Gear That Protects Against 52 Chemotherapy Drugs!
The Effects of the Nanosphere Carrier for the Combined Carmustine-Busulfan Trastuzumab in Human Breast Cancer Tissue Culture
Phase I Clinical and Pharmacological Study of O6-Benzylguanine Followed by Carmustine in Patients with Advanced Cancer1
A Guide to Safe Handling of Chemotherapy Drugs
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
Current FDA-Approved Therapies for High-Grade Malignant Gliomas
The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma
Gleostine (Lomustine) Capsules
Cancer Drug Costs for a Month of Treatment at Initial Food
NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010
Extract from the Clinical Evaluation Report for Aminolevulinic Acid Hcl
Bc Cancer Chemotherapy Preparation and Stability
NTP Monograph on the Systematic Review of Occupational Exposure to Cancer Chemotherapy Agents and Adverse Health Outcomes
Carmustine for Injection
Local Alkylating Chemotherapy Applied Immediately After 5-ALA Guided Resection of Glioblastoma Does Not Provide Additional Benefit
Top View
New Zealand Data Sheet 1. Product Name 2. Qualitative
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
Threshold of Toxicological Concern (TTC) for Anticancer Compounds
DRUG NAME: Lomustine
Carmustine Replacement in Intensive Chemotherapy Preceding Reinjection of Autologous Hscs in Hodgkin and Non-Hodgkin Lymphoma: a Review
208630Orig1s000
Local Alkylating Chemotherapy Applied Immediately After 5-ALA Guided Resection of Glioblastoma Does Not Provide Additional Benefit
Emetogenic Potential of Antineoplastic Agents
Current Treatments for Brain Tumors
Handling Cytostatic Drugs: Contents
Rapid Regression of Glioblastoma Following Carmustine Wafer Implantation: a Case Report
Association of High-Dose Cyclophosphamide, Cisplatin, And
Carmustine and Methotrexate in Combination After Whole Brain
Carmustine Obvius
A Randomized Trial of Amifostine and Carmustine-Containing Chemotherapy to Assess Lung-Protective Effects
Public Assessment Report
Pharmacist Involvement in the Management of Adverse Effects
Carmustine Obvius 100 Mg Powder and Solvent for Concentrate for Solution for Infusion
Clinical Challenges in Caring for Patients with Diabetes and Cancer
List of Off-Patent, Off-Exclusivity Drugs Without an Approved Generic
Pharmaceuticals Utilized in Stem Cell Transplant
Download Leaflet View the Patient Leaflet in PDF Format
Carmustine (Bicnu®) (“CAR Muss Teen”)
List of Drug Names & Synonyms
A New Mechanism of Action for the Anticancer Drug Mitomycin C: Mechanism-Based Inhibition of Thioredoxin Reductase † ‡ † † † Manuel M
BRAIN CANCER TREATMENT REGIMENS (Part 1 of 9) Clinical Trials: the NCCN Recommends Cancer Patient Participation in Clinical Trials As the Gold Standard for Treatment
Phase 1/2 Pilot Study of Methotrexate-Laurocapram Topical Gel for the Treatment of Patients with Early-Stage Mycosis Fungoides
Inhibition of Malignant Glial Cell Growth by Estramustine, an Estrogen
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Association of High-Dose Cyclophosphamide, Cisplatin, And
High-Dose Methotrexate-Based Regimens and Post-Remission
Chemotherapy and Other Hazardous Drugs: Safe Use Guidelines
CBV) Conditioning Before Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin’S Lymphoma
Primary Central Nervous System Lymphoma: a Narrative Review of Ongoing Clinical Trials and Goals for Future Studies
Carmustine Implants and Temozolomide for the Treatment of Newly Diagnosed High-Grade Glioma
Carmustine Implants and Temozolomide for the Treatment of Newly Diagnosed High-Grade Glioma Vol
Full Text (PDF)
Nitrosourea Chemotherapeutic Agents
360+Cancer Information SHEETS Foryou
MALIGNANT GLIOMA Experimental Studies with an Estrogen-Linked Cytostatic
Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections Valerie W. C. Soo1£, Brian W. Kwan 1£, Héctor Queza
K 23 I MAR 052013 FDA 510(K), Premarket Notification: 510(K) Summary of Safety and Effectiveness Information
Hazardous Drug List
Anticancer Dose Adjustment for Patients with Renal and Hepatic Dysfunction: from Scientific Evidence to Clinical Application
BCNU) and Etoposide (VP16-213) (CBV) and CBV Plus Cisplatin (CBVP) Followed by Autologous Stem Cell Transplantation in Patients with Hodgkin’S Disease